相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Defective apoptosis and tumorigenesis: role of p53 mutation and Fas/FasL system dysregulation
F Cappello et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2015)
Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53
Binghui Li et al.
CANCER LETTERS (2011)
Apoptosis in cancer: from pathogenesis to treatment
Rebecca S. Y. Wong
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Co-Treatment With Ginsenoside Rh2 and Betulinic Acid Synergistically Induces Apoptosis in Human Cancer Cells in Association With Enhanced Capsase-8 Activation, Bax Trans location, and Cytochrome c Release
Qing Li et al.
MOLECULAR CARCINOGENESIS (2011)
Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family
Tobias Schilling et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption
Jae-Sung Yi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The Many Roles of FAS Receptor Signaling in the Immune System
Andreas Strasser et al.
IMMUNITY (2009)
MECHANISMS OF CHEMOTHERAPEUTIC DRUG RESISTANCE IN CANCER THERAPY-A QUICK REVIEW
Fu-Shing Liu
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2009)
Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells
So-Young Kim et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Ginsenoside-Rh2-induced mitochondrial depolarization and apoptosis are associated with reactive oxygen species-and Ca2+-mediated c-Jun NH2-terminal kinase 1 activation in HeLa cells
Young-Mi Ham et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models
XW Xie et al.
JOURNAL OF UROLOGY (2006)
Caspase-3-dependent protein kinase C delta activity is required for the progression of Ginsenoside-Rh2-induced apoptosis in SK-HEP-1 cells
JI Oh et al.
CANCER LETTERS (2005)
Death receptors in chemotherapy and cancer
KM Debatin et al.
ONCOGENE (2004)
Mutation of P53 in head and neck squamous cell carcinoma correlates with BCL-2 expression and increased susceptibility to cisplatin-induced apoptosis
GA Andrews et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2004)
Ginsenoside Rh2 induces apoptosis via activation of caspase-1 and -3 and up-regulation of Bax in human neuroblastoma
YS Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2004)
Regulation of proliferation, survival and apoptosis by members of the TNF superfamily
U Gaur et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Apoptosis genes and resistance to cancer therapy - What do the experimental and clinical data tell us?
M Brown et al.
CANCER BIOLOGY & THERAPY (2003)
Mutant p53 gain of function:: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants
A Zalcenstein et al.
ONCOGENE (2003)
SEKI-dependent JNK1 activation prolongs cell survival during G-Rh2-induced apoptosis
YM Ham et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation
CL Brooks et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet
G van Loo et al.
CELL DEATH AND DIFFERENTIATION (2002)
Fas is involved in the p53-dependent apoptotic response to ionizing radiation in mouse testis
M Embree-Ku et al.
BIOLOGY OF REPRODUCTION (2002)
Differential expression of protein kinase C subtypes during ginsenoside Rha-induced apoptosis in SK-N-BE(2) and C6Bu-1 cells
YS Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2000)
Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells
YH Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
